What an FDA import alert is
An FDA import alert is a published directive that tells agency personnel to detain specified products, manufacturers, or countries without individual examination. For supplement brands, this is one of the highest-risk failure modes in FDA clearance, because the hold is automatic once a product or supplier appears on a watch list. The agency maintains a public import alert list that importers can check before they commit to a shipment.
Automatic detention without physical examination (DWPE)
Most import alerts operate as DWPE, which stands for detention without physical examination. Under DWPE, every entry that matches the alert is detained at the border without FDA opening the box. The importer must prove the product is compliant before it can be released, which reverses the normal flow of clearance.
This matters because a single flagged ingredient, claim, or facility can pull an entire line into detention. The issue is not the specific lot in front of the inspector. It is the category or source the alert covers.
Why supplements get targeted
Dietary supplements sit in a regulatory gap. They do not need pre-market approval like drugs, but they are still FDA-regulated, and the agency uses import alerts to intercept products it considers unsafe or misbranded. Supplements are an attractive target for DWPE because problems repeat across brands that share the same ingredient or contract manufacturer.
Our FDA import from China to the USA overview explains where supplements sit in the broader entry process, and an import alert is the sharpest version of that risk.
The most common supplement triggers
Several triggers appear repeatedly in supplement detentions:
- Unnotified new dietary ingredients. A new dietary ingredient (NDI) must be notified to FDA before it is used in a supplement sold in the US.
- Prohibited or questionable claims. Disease claims or drug-like language on supplement labels can trigger action.
- Contaminants. Heavy metals, microbes, or undeclared additives above limits lead to alerts.
- Known bad actors. A manufacturer or ingredient source already on an alert drags every future shipment with it.
- Missing verification. No FSVP importer program in place weakens the importer’s position during a detention.
What happens after a detention
When a shipment is detained under an import alert, the importer receives a notice and a chance to respond. Options are limited and depend on the alert type. Some alerts allow submission of private laboratory results to overcome the detention. Others require the underlying problem to be fixed at the source before any release is possible.
If the product cannot be cleared, the importer faces the disposal choices described in our guide on what happens when FDA refuses a shipment. Early detection is the best defense, so the ingredient import documents checklist should be completed before the goods leave the factory.
How to keep your products off the red list
Prevention is far cheaper than responding to a detention. Build these steps into product development and sourcing:
- Run an ingredient review before formulation, confirming NDIs are notified.
- Keep label claims within structure and function language, avoiding disease claims.
- Require a certificate of analysis for every batch, with contaminant limits stated.
- Vet contract manufacturers against the current import alert list.
- Maintain a documented FSVP program so the importer can show verification effort.
- File Prior Notice accurately, because mismatches raise scrutiny.
The common clearance mistakes list shows how small documentation gaps escalate into holds, so closing them early protects the whole supply chain.
Frequently asked questions
What is an FDA import alert?
An import alert is a published directive that tells FDA staff to detain specified products, manufacturers, or countries without individual examination. It is the main tool FDA uses to block repeat problem sources.
What does DWPE mean?
DWPE stands for detention without physical examination. Every entry matching the alert is detained at the border, and the importer must prove compliance before release.
Why are supplements often targeted?
Supplements need no pre-market drug approval but are still FDA-regulated. Problems such as unnotified ingredients or prohibited claims repeat across brands that share a source, which makes them candidates for watch-list detention.
Can I get a detained supplement released?
Sometimes. Certain alerts allow private lab results to overcome the detention. Others require the root cause to be fixed at the source first, and some cannot be released at all.
How do I check if a supplier is on an alert?
FDA publishes the import alert list by product, manufacturer, and country. Importers should screen contract manufacturers and ingredient sources against it before booking a shipment.
Does an import alert affect future shipments?
Yes. While the alert is active, matching products or sources are detained automatically. Fixing the underlying issue and having the alert removed is the only durable solution.